Skip to main content
. 2013 Jul 10;13:166. doi: 10.1186/1472-6882-13-166

Table 2.

IC50 of CACF or doxorubicin in melanoma A375 cells and normal primary melanocytes determined by MTT assays after 24 and 48 h treatment

  CACF
Doxorubicin
IC50 (mean ± SD) μg/mL IC50 (mean ± SD) μg/mL
 
24 h
48 h
24 h
48 h
A375
9.3 ± 2.5
8.5 ± 1.2
7.6 ± 0.8
6.2 ± 1.5
Primary melanocytes 24.3 ± 4.6 21.5 ± 3.1 8.5 ± 2.5 7.2 ± 2.2